DAWN MADKINS: Open Payments
NPI 1912406661 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 32 payments from 14 companies in 2025. Trend: 2023 $569 · 2024 $732 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $232 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Novo Nordisk Inc | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Viatris Specialty LLC | 2 | $62 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Boston Scientific Corporation | 1 | $29 |
| Corcept Therapeutics | 1 | $24 |
| Amgen Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, BREZTRI, YUPELRI, Ozempic, LINZESS, EPIDIOLEX, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
